FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia

January 25, 2013 -- The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). ALL is the most common type...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news